vTv Therapeutics Inc. (VTVT) Earnings History
Profitable13 years of earnings data (2013–2025) · Positive TTM net income
Loading earnings history...
vTv Therapeutics Inc. (VTVT) Earnings Overview
As of June 29, 2026, vTv Therapeutics Inc. (VTVT) reported trailing twelve-month net income of $2M, reflecting +0.0% year-over-year growth. The company earned $0.27 per diluted share over the past four quarters.
Looking at the long-term picture, VTVT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$8M in fiscal 2018.
vTv Therapeutics Inc. maintains positive profitability with. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including AVXL (-$40M net income), SAVA (-$106M net income), PRTA (-$151M net income, -2520.6% margin), VTVT has comparable earnings metrics. Compare VTVT vs AVXL →
VTVT Earnings vs Peers
Earnings metrics vs comparable public companies
VTVT Historical Earnings Data (2013–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$27M | -46.1% | -$33M | $-3.20 | - | - |
| 2024 | -$18M | +8.8% | -$24M | $-3.20 | -1815.3% | -2377.6% |
| 2023 | -$20M | -5.7% | -$26M | $-9.71 | - | - |
| 2022 | -$19M | -47.6% | -$23M | $-9.98 | -949.7% | -1116.9% |
| 2021 | -$13M | -52.8% | -$22M | $-8.29 | -324.3% | -540.9% |
| 2020 | -$8M | +61.3% | -$12M | $-7.21 | -132.5% | -184.8% |
| 2019 | -$22M | -177.3% | -$21M | $-28.97 | -793.7% | -755.9% |
| 2018 | -$8M | +51.0% | -$20M | $-25.42 | -63.6% | -159.4% |
| 2017 | -$16M | +1.3% | -$51M | $-66.62 | -5547.8% | -17416.5% |
| 2016 | -$16M | +40.5% | -$55M | $-68.52 | -2579.2% | -8678.2% |
| 2015 | -$27M | +23.8% | -$38M | $-132.90 | -5298.3% | -7349.1% |
| 2014 | -$36M | +25.1% | -$29M | $-173.87 | -2330.6% | -1865.5% |
| 2013 | -$48M | - | -$36M | $-234.57 | -4938.8% | -3671.4% |
Download Data
Export VTVT earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
13+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
VTVT — Frequently Asked Questions
Quick answers to the most common questions about buying VTVT stock.
What is VTVT earnings per share (EPS)?
VTVT trailing twelve-month (TTM) diluted EPS is $0.27, reflecting +0.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2013 to 2025 is available in the table on this page.
What is vTv Therapeutics Inc.'s net income?
vTv Therapeutics Inc. (VTVT) trailing twelve-month net income is $2M as of 2025. Earnings declined +0.0% year-over-year.
Is VTVT profitable?
Yes, VTVT is profitable with a TTM net income of $2M and a net profit margin of N/A.
What is VTVT's earnings growth rate?
VTVT compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2013 to 2025.
What are VTVT's profit margins?
vTv Therapeutics Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -68.5%.
Is VTVT growing earnings?
VTVT TTM EPS: $0.27. Net income: $2M. YoY earnings change: +0.0%.
What was VTVT's best earnings year?
vTv Therapeutics Inc.'s highest annual net income on record is $-8M, achieved in fiscal year 2018. Earnings history on this page spans 2013 to 2025 and includes all annual and quarterly figures.
What were VTVT's earnings last quarter?
VTVT's most recent reported quarter was Q1 2026. Net income was $24M with diluted EPS of $2.87. For a full breakdown of all quarters, see the quarterly earnings table on this page.